Výsledky vyhledávání - Nigel H. Russell

Upřesnit hledání
  1. 1
    Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia

    Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia Autor Alan K. Burnett, Nigel H. Russell, Robert K. Hills

    Vydáno 2016
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  2. 2
    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML) Autor Richard Dillon, Nicola Potter, Sylvie D. Freeman, Nigel H. Russell

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Targeting FLT3 mutations in AML: review of current knowledge and evidence

    Targeting FLT3 mutations in AML: review of current knowledge and evidence Autor Naval Daver, Richard F. Schlenk, Nigel H. Russell, Mark J. Levis

    Vydáno 2019
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

    Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution Autor Phennapha Klangsinsirikul, G. Ian Carter, Jenny Byrne, G Hale, Nigel H. Russell

    Vydáno 2002
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia

    Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia Autor Erica Harris, Judith Behrens, D Samson, Amin Rahemtulla, Nigel H. Russell, Jenny Byrne

    Vydáno 2003
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  6. 6
    The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation

    The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation Autor Mohamad Mohty, Rafael F. Duarte, Sandra Croockewit, Kai Hübel, Gunnar Kvalheim, Nigel H. Russell

    Vydáno 2011
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  7. 7
    HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants

    HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants Autor Bronwen E. Shaw, Steven G. E. Marsh, Neema P. Mayor, Nigel H. Russell, J. Alejandro Madrigal

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

    Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation Autor Nigel H. Russell, Jenny Byrne, Rowena D. Faulkner, M Gilyead, Emma Das‐Gupta, Alexandria Porcia Haynes

    Vydáno 2005
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

    Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy Autor Sahra Ali, Gail Jones, Dominic Culligan, Philippa J. Marsden, Nigel H. Russell, Nicholas D. Embleton, Charles Craddock

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    The genotype distribution of the XRCC1gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

    The genotype distribution of the XRCC1gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia Autor Claire Seedhouse, Rowena D. Bainton, Michael D. Lewis, A. Lynn Harding, Nigel H. Russell, Emma Das‐Gupta

    Vydáno 2002
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Granulocyte-Colony–Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke

    Granulocyte-Colony–Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke Autor Nikola Sprigg, Philip M. Bath, Liancheng Zhao, Mark Willmot, Laura J. Gray, Marion Walker, Martin Dennis, Nigel H. Russell

    Vydáno 2006
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

    Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial Autor Nigel H. Russell, Alan K. Burnett, Robert K. Hills, Sophie Betteridge, Mike Dennis, Jelena Jovanović, Richard Dillon, David Grimwade

    Vydáno 2018
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

    Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Part... Autor Stephen Robinson, Anthony H. Goldstone, Stephen Mackinnon, Angelo Michele Carella, Nigel H. Russell, Carmen Ruiz de Elvira, Goli Taghipour, Norbert Schmitz

    Vydáno 2002
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission

    Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission Autor Alan K. Burnett, Anthony P. Goldstone, Robert K. Hills, Donald Milligan, Archie Prentice, John Yin, Keith Wheatley, Ann Hunter, Nigel H. Russell

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial Autor Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Ann E. Hunter, Lars Kjeldsen, John Liu Yin, Brenda Gibson, Keith Wheatley, Donald Milligan

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials

    No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials Autor Rosemary E. Gale, Teodora Popa, Melissa Wright, Naeem Khan, Sylvie D. Freeman, Alan K. Burnett, Nigel H. Russell, Robert K. Hills, David C. Linch

    Vydáno 2017
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial

    Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial Autor Alan K. Burnett, Jamie Cavenagh, Nigel H. Russell, Robert K. Hills, Jonathan Kell, Gail Jones, Olav Wendelboe Nielsen, Asim Khwaja, Ian Thomas, Richard E. Clark

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation

    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Bl... Autor Gordon Cook, Graeme Smith, Keiren Kirkland, Jungwha Lee, Rachel Pearce, Kirsty Thomson, Emma Morris, Kim Orchard, Simon Rule, Nigel H. Russell, Charles Craddock, David I. Marks

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial Autor Alan K. Burnett, Robert K. Hills, Donald Milligan, Lars Kjeldsen, Jonathan Kell, Nigel H. Russell, John A. Liu Yin, Ann Hunter, Anthony H. Goldstone, Keith Wheatley

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT

    Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT Autor David Burns, Sohail Rana, Elizabeth Martin, Sandeep Nagra, Janice Ward, Husam Osman, Andrew Bell, Paul Moss, Nigel H. Russell, Charles Craddock, Christopher P. Fox, Sridhar Chaganti

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: